Inhibition of Na + -H + Exchange Prevents Hypertrophy, Fibrosis, and Heart Failure in β 1 -Adrenergic Receptor Transgenic Mice
- 19 April 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 90 (7) , 814-819
- https://doi.org/10.1161/01.res.0000014966.97486.c0
Abstract
Chronic stimulation of the β1-adrenergic receptor leads to hypertrophy and heart failure in β1-adrenergic receptor transgenic mice and contributes to disease progression in heart failure patients. The cellular mechanisms underlying these detrimental effects are largely unknown. In this study, we have identified the cardiac Na+-H+ exchanger (NHE1) as a novel mediator of adrenergically induced heart failure. β1-Adrenergic receptor transgenic mice showed upregulation of both NHE1 mRNA (+140±6%) and protein (+42±19%). In order to test whether increased NHE1 is causally related to β1-adrenergic–induced hypertrophy, fibrosis, and heart failure, β1-adrenergic receptor transgenic (TG) and wild-type (WT) littermates were treated with a diet containing 6000 ppm of the NHE1 inhibitor cariporide or control chow for 8 months. There was significant hypertrophy of cardiac myocytes in β1-adrenergic receptor transgenic mice (2.3-fold increase in myocyte cross-sectional area), which was virtually absent in cariporide-fed animals. Interstitial fibrosis was prominent throughout the left ventricular wall in nontreated β1-adrenergic receptor transgenic mice (4.8-fold increase in collagen volume fraction); cariporide treatment completely prevented this development of fibrosis. Left ventricular catheterization showed that cariporide also prevented the loss of contractile function in β1-adrenergic receptor transgenic mice: whereas untreated transgenic mice showed a significant decrease in left ventricular contractility (5250±570 mm Hg/s TG versus 7360±540 mm Hg/s WT, dp/dtmax), this decrease was completely prevented by cariporide (8150±520 mm Hg/s TG cariporide). Inhibition of NHE1 prevented the development of heart failure in β1-receptor transgenic mice. We conclude that the cardiac Na+-H+ exchanger 1 is essential for the detrimental cardiac effects of chronic β1-receptor stimulation in the heart.Keywords
This publication has 19 references indexed in Scilit:
- Beta-adrenoceptors in cardiac diseasePublished by Elsevier ,2002
- Early impairment of calcium handling and altered expression of junctin in hearts of mice overexpressing the β 1 − adrenergic receptorThe FASEB Journal, 2001
- The Myocardial Na+/H+ ExchangerDrugs, 2001
- Myocardial-Directed Overexpression of the Human β1-Adrenergic Receptor in Transgenic MiceJournal of Molecular and Cellular Cardiology, 2000
- Rational basis for use of sodium–hydrogen exchange inhibitors in myocardial ischemiaThe American Journal of Cardiology, 1999
- Both Gs and Gi Proteins Are Critically Involved in Isoproterenol-induced Cardiomyocyte HypertrophyJournal of Biological Chemistry, 1999
- The Mitogen-activated Protein Kinase Kinase MEK1 Stimulates a Pattern of Gene Expression Typical of the Hypertrophic Phenotype in Rat Ventricular CardiomyocytesPublished by Elsevier ,1995
- Activation of Na+-H+ Antiporter (NHE-1) gene expression during growth, hypertrophy and proliferation of the rabbit cardiovascular systemJournal of Molecular and Cellular Cardiology, 1995
- The sodium/hydrogen exchange system in cardiac cells: Its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pHJournal of Molecular and Cellular Cardiology, 1985
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984